Stocksigma LogoStocksigma Logo

Anthem Biosciences Schedules Board Meeting to Approve Q2 and H1'27 Results

Anthem Biosciences Limited announced that its Board of Directors will meet on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated

Anthem Biosciences Schedules Board Meeting to Approve Q2 and H1'27 Results

Anthem Biosciences Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Anthem Biosciences Schedules Board Meeting to Approve Q2 and H1'27 Results Anthem Biosciences Limited announced that its Board of Directors will meet on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in the company's equity shares remains closed from 1st Oct'26 until the close of trading hours on 5th Nov'26, which is 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Anthem Biosciences Ltd

All Anthem Biosciences Ltd announcements